Picard Medical Appoints Interim CEO, Reports 85% Q1 Revenue Growth
Richard Fang assumed the role of Interim CEO following Patrick's departure, and the company reported a 85% year-over-year revenue increase. This update highlights strong operational momentum and manufacturing progress despite the leadership transition.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day